Article
PET imaging of oncolytic VSV expressing the mutant HSV-1 thymidine kinase transgene in a preclinical HCC rat model.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Apr 2015
Muñoz-Álvarez Kim A, Altomonte Jennifer, Laitinen Iina, Ziegler Sibylle, Steiger Katja, Esposito Irene, Schmid Roland M, Ebert Oliver
Abstract excerpt
Hepatocellular carcinoma (HCC) is the most predominant form of liver cancer and the third leading cause of cancer-related death worldwide. Due to the relative ineffectiveness of conventional HCC therapies, oncolytic viruses have emerged as novel alternative treatment agents. Our previous studies have demonstrated significant prolongation of survival in advanced HCC in rats after oncolytic vesicular stomatitis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
